Compound class:
Synthetic organic
Comment: PHTPP-1304 is a novel protein degrader [1-2]. It binds to the estrogen receptor β via the ERβ antagonist PHTPP domain, and simultaneously to the autophagy receptor p62, to target the ERβ . This class of degrader is called an AUTOphagy-TArgeting Chimera, or AUTOTAC. AUTOTACs can be designed to target proteins of interest to autophagic membranes where they undergo lysosomal degradation, in a proteasome-independent manner.
|
|
References |
1. Ji CH, Kim HY, Lee MJ, Heo AJ, Park DY, Lim S, Shin S, Ganipisetti S, Yang WS, Jung CA et al.. (2022)
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system. Nat Commun, 13 (1): 904. [PMID:35173167] |
2. Kwon YT, Ji CH, Ganipisetti S, Kim HY, Mun SR, Jung CH, Jung EJ, Sung KW. (2021)
Novel autophagy-targeting chimera (autotac) compound, and composition for preventing, alleviating, or treating diseases through target protein degradation comprising same. Patent number: EP3828164A1. Assignee: Protech Co Ltd. Priority date: 24/07/2018. Publication date: 02/06/2021. |